Distribution & Logistics
R & D
Why Choose Us
Major Break Throughs
Products In Pipeline
Board of Directors
Share Holding Patterns
Corporate Governance  >>
Code of Conduct
Live Stock in NSE
Live Stock in BSE
Detailed NCLT Petition   >>
Career & Growth
HR Contact Details
Ind-Swift in News
ISL Empire 2014
Code of Fair Disclosure
T & C of Appointment
Party Transaction Policy
Risk Management Policy
Whistle Blower Policy
Composition of Committees
Annexure i to xii of Petition
Annexure xiii-list of Depositors
List Of FD Holders
Annexure xiv to xvi of Petition
Research & Development
R & D Infrastructure
Pocketed two patent of Clarithromycin & Fexofenadine.
Taste masking technology of macrolides for the first time in India.
Development of NDDS for old and new molecules.
Developing non infringing process of four products.
Unique tablet in tablet technology.
Development of sustained release process of Isoxsuprine HCL tablets first time in India.
Researching such ayurvedic medicinal plants which show a promise in treating chronic ailments, conditions and life style disorders.
Development of mouth dissolving tablet technique.
Development of Netazoxanide based formulations single & in combination with ofloxacin, first in the country.
Received US and EU patent for Extended Release dosage form of Clarithromycin.
Received European patents for the taste masked formulations of Fexofenadine for pediatrics.
Developed tasteless, directly compressible, fast dissolving, Fexofenadine carboner complex to be used in all solid dosage form of fexofenadine for all age groups .
Developed soluble and stable Macrolide citrate salts to be used in all solid dosage form of Macrolide especially in modified release forms.
Developed Netazoxanide an Anti-diarrheal drug for the first time in India after successful clinical trials and Bioequivalence studies.
Development of Once Daily (OD) of Clarithromycin.
Development of liquid Preparation of Fexofenadine .
Copyright © 2012 | All Rights Reserved
Website Designed by:
3M Advertisers And Publishers Limited